Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B
Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.
Nature21h
Aims and scope
Humanities & Social Sciences Communications is a fully open-access, online journal publishing peer-reviewed research from across—and between—all areas of the humanities, behavioral and social ...